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Measuring tuberculosis transmission is exceedingly difficult, given the remarkable variability in the timing of clinical disease after 
Mycobacterium tuberculosis infection; incident disease can result from either a recent (ie, weeks to months) or a remote (ie, several 
years to decades) infection event. Although we cannot identify with certainty the timing and location of tuberculosis transmission 
for individuals, approaches for estimating the individual probability of recent transmission and for estimating the fraction of tuber-
culosis cases due to recent transmission in populations have been developed. Data used to estimate the probable burden of recent 
transmission include tuberculosis case notifications in young children and trends in tuberculin skin test and interferon γ–release 
assays. More recently, M. tuberculosis whole-genome sequencing has been used to estimate population levels of recent transmission, 
identify the distribution of specific strains within communities, and decipher chains of transmission among culture-positive tuber-
culosis cases. The factors that drive the transmission of tuberculosis in communities depend on the burden of prevalent tuberculosis; 
the ways in which individuals live, work, and interact (eg, congregate settings); and the capacity of healthcare and public health sys-
tems to identify and effectively treat individuals with infectious forms of tuberculosis. Here we provide an overview of these factors, 
describe tools for measurement of ongoing transmission, and highlight knowledge gaps that must be addressed.
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Mounting evidence from countries with high tuberculosis bur-
dens and varying prevalences of human immunodeficiency 
virus (HIV) infection points to ongoing transmission as the 
driving force maintaining tuberculosis incidence; this evidence 
appears to be even more pronounced for multidrug-resistant 
tuberculosis (MDR-TB) and extensively drug-resistant tubercu-
losis (XDR-TB) [1–3]. The intensity of local tuberculosis trans-
mission is dependent on the prevalence (and infectiousness) of 
individuals with infectious forms of tuberculosis, the number 
(and susceptibility) of individuals with whom infectious individ-
uals may contact, the frequency and proximity of interactions 
between infectious and susceptible individuals, as well as biolog-
ical features of Mycobacterium tuberculosis (the pathogen) that 
affect transmission. Each of these factors can differ by setting; for 
example, the prevalence and infectiousness of individuals may 
be affected by individual-level attributes (eg, HIV coinfection) 
or by shared, community-level attributes (eg, accessibility of 
diagnosis and quality of care). Social-mixing patterns are influ-
enced by age and demographic structure, cultural behaviors, 
population density, and migration patterns. Environmental fac-
tors, such as crowding and ventilation, have a direct impact on 
the person-to-person air exchange necessary for transmission. 
In addition, ways in which different strains of M.  tuberculosis 
may be adapted for airborne survival, tuberculosis aerobiology, 
and successful infection are subjects of increasing research [4–6].
Measuring tuberculosis transmission and estimating the rel-
ative importance of recent transmission is exceedingly difficult, 
given that infection in only a minority of individuals will prog-
ress to disease and that the periods of latency among individuals 
with infection that do progress are variable. The infectiousness 
of tuberculosis cases can be defined clinically, including the 
presence of cough and acid-fast organisms in sputum, when 
individuals have not yet received effective tuberculosis ther-
apy. However, infectiousness may be present prior to the onset 
of symptoms [7–9]. In fact, there is a spectrum in the clinical 
course of tuberculosis [10] inclusive of: subclinical tuberculo-
sis (characterized by negative results of tuberculosis symptom 
screening but positive results of culture, with tuberculosis pre-
sumably infectious); prediagnostic disease (characterized by 
symptoms that are sufficiently noticeable for detection during 
symptom screening but not sufficiently severe to seek medical 
care); and clinical disease (characterized by active seeking of 
care for symptoms, although often after delays due to difficulties 
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differentiating between other respiratory tract infections in set-
tings where clinical diagnosis remains standard practice) [11]. 
Given these complexities, including the independent nature of 
these parameters, the relative contributions of highly infectious 
individuals versus apparently asymptomatic but infectious indi-
viduals in settings of high tuberculosis endemicity is uncertain.
This article, an output of a workshop entitled “How Do We 
Measure Tuberculosis Transmission Better,” discusses the main 
themes of the measurement of tuberculosis transmission and 
specific drivers of tuberculosis transmission, the character-
ization of infectious and susceptible individuals, and how we 
can use this information to model and halt tuberculosis trans-
mission. The overarching goal of the workshop was to identify 
research gaps to address as a critical step in the development 
of novel interventions to stop tuberculosis transmission in 
high-incidence settings.
FACTORS INFLUENCING TUBERCULOSIS 
TRANSMISSION
The probability that an individual with tuberculosis will transmit 
M. tuberculosis to others is determined by many factors. First, indi-
viduals with more severe pulmonary tuberculosis may emit higher 
numbers of infectious droplet nuclei by producing droplets at an 
elevated rate [12, 13]. The rate of droplet production may be affected 
by the frequency and vigor of coughing and by pathology-related 
factors that allow pathogens to escape into the airway (eg, cavities) 
[14]. Recent work suggests that measures of cough aerosol produc-
tion may identify individuals more likely to contribute to commu-
nity transmission [15, 16]. Closer proximity and longer duration 
of contact between an infectious source case and susceptible indi-
viduals increase the risk of transmission. Delays in the diagnosis of 
tuberculosis or initiation of adequate treatment increase the preva-
lence of infectious tuberculosis, thereby also increasing the proba-
bility of onward transmission [17, 18]. Contributions to treatment 
delay include individual healthcare-seeking behavior, structural 
barriers to healthcare access, and rapidity of diagnosis and treat-
ment initiation within the health system.
Second, environmental factors that may increase the risk of 
infection include closed indoor spaces with limited air circu-
lation and minimal UV light exposure, which provide an ideal 
environment for airborne particles containing M.  tuberculosis 
to remain viable and infectious. Humidity also affects the set-
tling and evaporation of droplet nuclei and thus likely affects 
the risk of infection [12].
Third, host factors may increase an individual’s risk of pro-
gression to active pulmonary disease after infection. Host-
related determinants of disease risk include HIV infection [19], 
diabetes [20], smoking [21], excess alcohol use [22], and mal-
nutrition [23]. The degree of infectiousness of the inoculum (ie, 
dose) also may influence the likelihood of disease [24]. Young 
children and infants, having both recent exposure by nature and 
a higher risk of rapid progression, can act as sentinel populations 
for ongoing transmission. However, they rarely contribute to 
ongoing transmission, owing to their decreased infectiousness 
[25, 26]. In older populations, incident  tuberculosis is a less reli-
able measure of ongoing transmission because of difficulties in 
identifying the timing of infection and distinguishing between 
reactivation of latent infection and early active disease [10].
MEASUREMENT OF TUBERCULOSIS  
TRANSMISSION
Four main approaches are used to measure tuberculosis transmis-
sion and identify its drivers. The first approach is case notification 
rates, which are used to identify countries and regions in which the 
risk of tuberculosis is high [27]. Notification rates also may yield 
temporal trends in transmission [28]; furthermore, they can be 
used to identify the heterogeneity of risk in subpopulations, such 
as a higher risk in low-incidence settings among foreign-born 
persons, prisoners, and those experiencing homelessness [29], as 
well as heterogeneity of risk among community locations within 
high-incidence settings (eg, public transportation [30], churches 
[31], schools [32, 33], bars [31], and slums [34–36]). Second, one 
can estimate the risk of being infected and identify risk factors 
for being infected. This approach uses the tuberculin skin test 
and interferon γ–release assays to identify infections. Estimates 
of trends in the annual risk of infection have been derived from 
repeated surveys, often including primary school children 
[37–39]. Repeated surveys have shown a higher risk of infection 
among adolescents than among children of primary school age 
[40, 41]. However, repeated cross-sectional studies are sensitive 
to prior changes in transmission at earlier ages, although rever-
sion of tuberculin skin test and interferon γ–release assay find-
ings may result in an underestimate of M. tuberculosis infection 
rates. Furthermore, in high transmission settings, repeat infection 
episodes cannot be easily identified with these types of infection 
assays that provide some measure of cumulative exposure. To 
estimate newly acquired infection, screening for M. tuberculosis 
infection can also be done in contact investigations and among 
high-risk groups, such as immigrants from high-burden countries 
or healthcare workers. Since molecular strain typing became avail-
able in the 1990s [42], a third approach, assessing the genotypic 
links between presumed index tuberculosis cases and their pre-
sumed secondary cases, has become possible. At the population 
level, methods such as n − 1 and other modeling-based techniques 
have been developed to estimate levels of recent transmission, 
based on genotypic clustering [43–46]. Molecular epidemiologi-
cal studies have also confirmed that adolescents are a high-risk 
group for tuberculosis transmission, established the importance 
of nosocomial transmission [34], and identified other risk factors 
for recent transmission, including urban residence, homelessness 
[47], and exposure to crowded settings, such as prisons [48, 49]. 
Over time, the resolution of strain typing has improved; whole-ge-
nome sequencing (WGS) now provides the ultimate ability to dis-
tinguish strains on the basis of single nucleotide differences, as 
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described in the next section below [50]. It is worth noting that 
the first and third methods depend in part on transmission and in 
part on the risk of progression from infection to disease. A fourth 
and indirect approach has been the characterization of source 
cases. Traditionally, measures of bacillary load based on sputum 
smear and the presence and extent of pulmonary cavitation have 
been used to estimate the infectiousness of source cases as a proxy 
for the expected number of infected contacts and secondary cases 
[51]. More recently, new measures of infectiousness have been 
developed [4, 6].
Other approaches to identify drivers of transmission have 
included contact surveys [32] and a recently developed method 
combining time and motion studies with measurement of CO2 in 
air as a measure of exhaled air [30]. These methods and their appli-
cation and limitations are described in another article in this issue.
ASSESSING TRANSMISSION BY USING MOLECULAR 
AND GENOMIC EPIDEMIOLOGICAL METHODS
Since the MDR-TB outbreaks in the 1990s in the United States, 
genotyping of M. tuberculosis isolates has been a critical element 
for studying tuberculosis transmission [44, 52]. A crucial aspect 
in understanding the transmission patterns of tuberculosis is 
the ability to track the frequency and spread of specific strains 
in the population [53]. Although previous genotyping methods 
(eg, IS6110-based restriction fragment–length polymorphism 
analysis and mycobacterial interspersed repetitive units vari-
able number of tandem repeats analysis) are informative, these 
methods have limited discriminatory power. Newer methods, 
which are able to examine much more of the genome, suggest 
that some genotype matches between two patients’ isolates 
might not indicate recent transmission. Therefore, outbreaks 
confirmed by molecular methods in the 1990s and 2000s may 
have overestimated the number of cases that were truly part of 
a transmission chain [54]. The enhanced level of discrimination 
achieved by WGS is particularly important for characterizing the 
actual diversity of strains within a given lineage or genotype that 
appear to be closely related and for helping to rule out recent 
transmission when epidemiologic links have not been estab-
lished [54]. The continual decline in costs, increased computing 
power, and ease of data sharing have facilitated access to WGS as 
a tool for investigating tuberculosis transmission.
Phylogenetic analysis using WGS data can detail strain relat-
edness at unprecedented levels of granularity (ie, single-nu-
cleotide polymorphisms [SNPs]). Such data have been used to 
support estimates of levels of incident tuberculosis due to trans-
mission in a variety of settings [1, 2, 54, 55]. A key question is: 
what levels of genetic variation are suggestive of transmission? 
The level of WGS data–based similarity (ie, the threshold of 
SNP differences) that is sufficient to consider two isolates related 
has proven difficult to establish. Most large-scale studies to date 
have used empirical SNP difference cutoffs, typically supported 
by epidemiological investigations [1, 55]. There are a number 
of factors to consider in determining levels of genetic variation 
in support of transmission. The average mutation rate in M. 
tuberculosis is estimated at 0.3–0.5 SNPs/genome/year between 
patient samples. However, considerable within-host variation 
has been noted in serial patient isolates, as well as in specimens 
from discrete environments of the lung [56–60]. The mutation 
rate also may vary on the basis of M. tuberculosis lineage or host 
characteristics, such as HIV coinfection [56–59]. More recently, 
methods to infer person-to-person transmission by using 
genomic information that consider within-host variation [61] 
and account for the complex and variable nature of case sam-
pling (ie, undersampling) have been developed [62]. However, 
factors that impact heterogeneity are likely to be dependent on 
individual-level (eg, HIV status) and ecological-level (eg, force 
of infection) factors. A study by Chengalroyen et al details the 
presence of differentially culturable M. tuberculosis with mixed 
genotypes that vary by HIV status, a finding that warrants fur-
ther investigation [63].
IDENTIFYING AND DEFINING TUBERCULOSIS 
OUTBREAKS
Tuberculosis outbreaks typically present the clearest evidence 
of tuberculosis transmission, as they are often spatiotemporally 
restricted and involve shared epidemiological attributes. A first 
question is whether an unexpected number of tuberculosis cases, 
clustered by space and time, is indeed an outbreak. Epidemiologic 
studies have shown that tuberculosis does not afflict all suscepti-
ble individuals equally; therefore, an aggregation of individuals 
with risk factors for tuberculosis, such as in a hospital or prison, 
may actually represent a pseudo-outbreak. To establish that there 
has been M. tuberculosis spread from a source patient to multiple 
secondary cases, investigators can use molecular or genomic typ-
ing methods to demonstrate clonal dissemination.
By studying tuberculosis outbreaks defined by strain typing 
methods, it is possible to ask whether there are host, pathogen, 
and environmental factors significantly associated with recently 
transmitted disease. A caveat is that the study duration should 
account for M. tuberculosis latency (eg, a 1-year study cannot 
define risk factors for becoming infected and developing disease 
in 18 months). As such, molecular epidemiologic investigations 
of tuberculosis outbreaks do not measure transmission com-
pletely. Instead, they identify risk factors for the subset of new 
infections that rapidly progress to culture-confirmed tubercu-
losis. For defining a preventive intervention, this may be valu-
able information. However, such findings may be insufficient 
for understanding all of the determinants contributing to the 
original transmission events.
An important consideration when investigating risk factors 
for being a case in an outbreak defined by strain typing methods 
is whether the source is truly known. When grouping together 
index and secondary cases on the basis of a shared genotype, 
some individuals may have smear-negative pulmonary disease. 
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These cases, which most likely reflect primary disease in sec-
ondary cases, might be included in a risk-factor analysis of 
the environment but excluded from an investigation of source 
predictors of transmission. Such approaches risk certain lim-
itations. If, for example, the index and five secondary cases are 
included in the analysis of the environment, is one truly obtain-
ing six independent measurements that can go into a statistical 
model? Or is the same environmental factor (eg, household or 
prison ward) being repeated six times? And if the secondary 
cases are excluded, how confident are we that the first case or 
the epidemiologically suspected index that we included is truly 
the one that initiated the outbreak? It is well established that an 
infant with tuberculosis triggers a source investigation to iden-
tify the adult with contagious tuberculosis; in a larger outbreak, 
the directionality of transmission may not always be apparent. 
For instance, in an apparent outbreak of 50 culture-confirmed 
tuberculosis cases in northern Canada, WGS identified six 
subgroups of clonal spread; in one, an individual brought to 
medical attention as a contact was later found to be a source 
case, based on cavitary, smear-positive disease and WGS data 
[64]. Given that WGS defines outbreak-related cases better 
than older strain typing modalities but also suggests a putative 
directionality of transmission (ie, based on the accumulation of 
SNPs relative to most common recent ancestor), it is possible 
that a refined understanding of the drivers of transmission in 
epidemiologically well-defined settings will emerge from the 
application of this technology. However, SNP-based definitions 
to support transmission in relatively short time scales are not 
well established and are likely to be contextually dependent (ie, 
high-incidence versus low-incidence areas).
A final consideration that has received limited attention is 
the characteristics of the inoculum. Classically, the most-con-
tagious patients are those who cough and those with untreated, 
smear-positive and cavitary disease. As these parameters are 
readily estimated by history (cough and treatment) and rela-
tively simple tests (microscopy and radiography), it remains 
practical to use them to help guide patient care, as well as a 
standard for estimating infectivity (however an insensitive 
tool it might be) to guide public health assessments, includ-
ing in children, people with HIV infection, and patients with 
extrapulmonary disease (although the sensitivity of smear 
microscopy falls to <50% in these groups). But several ques-
tions exist. Are these independent indicators or merely cor-
related measures of the same process (ie, density of bacteria 
being spread from a patient)? Is the number of bacteria in the 
liquid phase of sputum an appropriate proxy for the number 
of bacteria expired in air from an individual with tuberculo-
sis? Can we use genome equivalents from PCR-based assays 
to more accurately quantify bacterial burden in sputum, as 
a continuous rather than dichotomous variable? Answering 
these questions may additionally help to evaluate new thera-
pies for treatment of tuberculosis.
HETEROGENEITY OF TRANSMISSION: WHERE IS 
TUBERCULOSIS TRANSMITTED?
Several studies conducted in Africa have estimated the propor-
tion of transmission occurring within households. In comparing 
genotypes of cases occurring within households or community 
settings, Verver et al estimated that <20% of infections were 
acquired within the household [65]. A study from South Africa 
used social contact diaries and portable CO2 monitors to infer 
exposures in a township with a high tuberculosis burden; an 
estimated 16% of infections occurred within households [32], 
which was confirmed by molecular epidemiologic findings [66]. 
Martinez et al performed a meta-analysis of studies reporting M. 
tuberculosis infection among children in households with and 
those without a household contact to estimate the population 
attributable fraction of household exposure [67]; their estimate 
of 14% (95% confidence interval, 11.6%–16.3%) was consistent 
with estimates from these other approaches in settings where 
the tuberculosis incidence is high [32, 66]. In addition, Glynn 
et al conducted surveillance for >13 years in a district in rural 
Malawi, using contact questionnaires and WGS; they found that 
a minority of tuberculosis cases could be attributed to infection 
from known contacts [68]. Overall, it appears that in medi-
um-burden and high-burden areas, the majority of tuberculosis 
transmission occurs outside of households and may not neces-
sarily be attributed to known close contacts; this suggests that 
the population-level impact of contact investigations, as a con-
trol measure in these areas, warrants further consideration (see 
the subsection “Areas of High Tuberculosis Incidence” below) 
[69]. Nevertheless, a regionally and culturally appropriate, bal-
anced approach is needed; at the patient level, contact investiga-
tions are likely to yield a greater proportion of new tuberculosis 
cases than any other case finding approach.
However, determining where tuberculosis transmission spe-
cifically occurs outside of households is considerably more chal-
lenging. The potential for airborne transmission to occur even 
during brief exposures, combined with the variable periods of 
latency, make establishing specific tuberculosis transmission 
linkages exceptionally difficult. Despite these challenges, certain 
specific settings have been identified as substantial contributors 
to tuberculosis risk. Nosocomial transmission was a major driver 
of MDR-TB outbreaks in the United States, Spain, and Italy in the 
1990s [70–73]; hospital-associated transmission was also respon-
sible for the explosive dissemination of XDR-TB in a rural South 
African district in the mid-2000s [74]. Homeless shelters have 
been frequently identified as drivers of tuberculosis outbreaks 
[75]. Prisons have similarly been sources of not only incident 
outbreaks in low-burden countries [76] but also high levels of 
endemic transmission in low-income and middle-income coun-
tries [77]. Using national tuberculosis notification data from Brazil, 
Bourdillon et al found that >25% of all incident cases among men 
aged 20–29 years occurred within prisons, where notification rates 
were 31 times greater than in the general population [1, 78]. Other 
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high-risk community settings implicated in tuberculosis trans-
mission include public transportation [30], churches [31], schools 
[32, 33], bars [31], and slums [34–36].
The concentration of tuberculosis transmission in certain set-
tings and subpopulations also leads to transmission heterogene-
ity, which can act to increase the effective reproductive number 
[79] and may make control of transmission more difficult. Basu 
et  al described these settings as “institutional amplifiers” and 
demonstrated how they can increase incidence even when high 
levels of case detection and treatment success are established 
in the broader community [80]. By understanding the settings 
and groups at high risk for tuberculosis, however, we can more 
efficiently target interventions to achieve tuberculosis control. 
For example, Dowdy et al modeled data from Rio de Janeiro and 
demonstrated that targeting interventions to high-risk slum 
areas where 6% of the population resides could be as effective in 
reducing tuberculosis as equivalent measures conducted for the 
other 94% of the population [81].
Areas of High Tuberculosis Incidence
In high-incidence areas, both epidemiologic and molecular 
studies have consistently shown that the majority of tubercu-
losis transmission does not come from known contacts [65, 66, 
68, 82–87]. For example, in northern Malawi, estimates based 
on case-control studies, RFLP-based studies, and studies using 
WGS all concluded that the proportions of tuberculosis cases 
attributable to known contacts was <15% [68, 83, 84]. Perhaps 
most surprising was the finding that more than half of the indi-
viduals with tuberculosis who had contact with a smear-posi-
tive case in their household or in a close family member had a 
different strain than that contact, showing that this person was 
not the source of their infection [68, 84].
 These findings raise questions on the timing of infection(s) 
and where most infections are occurring. Work on the dynam-
ics of aerosols suggests that infections are likely to be occurring 
mainly in indoor areas where air exchange is limited [4, 88]. This 
may include places where people are crowded together, although 
direct evidence is currently limited [66, 89]. Lack of ventilation 
may contribute to the high tuberculosis incidence in colder areas, 
such as the Western Cape of South Africa, and may have con-
tributed to the spread of tuberculosis in Europe a century ago. 
It may also explain the paradoxical finding that tuberculosis 
incidence may be lower than expected among poorer families in 
rural Africa; they are less likely than those who are less poor to 
have glass windows, meet indoors, or use minibuses [90, 91]. In 
estimating setting-specific proportions of individuals with tuber-
culosis who transmit disease, the higher risk due to close, indoor 
contact needs to be balanced against the frequency of such con-
tacts; more transmissions may occur from many low-risk con-
tacts than from fewer high-risk ones [92].
Many areas of high tuberculosis incidence also have a high 
HIV prevalence. Clinics that provide HIV care can be potential 
amplifiers of tuberculosis epidemics when patients with undiag-
nosed tuberculosis mix with immunologically susceptible indi-
viduals. However, the effect of HIV itself on transmission appears 
to be more complex. Patients with tuberculosis who are infected 
with HIV are less likely to have smear-positive disease, and even 
those with smear-positive disease may transmit less than those 
who are HIV negative [66, 84]. This may be because they seek 
treatment or die earlier, shortening the duration of infectiousness. 
Nevertheless, because a high proportion of tuberculosis cases are 
HIV positive, they may contribute a large proportion of transmis-
sion events [84]. A study of tuberculosis among gold miners found 
that incidence increased following the HIV epidemic among HIV-
negative and HIV-positive South African miners, showing that M. 
tuberculosis transmission increased overall [93]. Antiretroviral 
therapy, which reduces the risk of tuberculosis in HIV-infected 
individuals [94], has reduced tuberculosis incidence at the pop-
ulation level (at least in the short term) [95, 96]. However, even 
when antiretroviral therapy is available, transmission indices may 
remain high. A study in KwaZulu Natal, South Africa, a HIV 
endemic setting, found that despite high antiretroviral therapy 
coverage among XDR TB patients with HIV, upwards of 70% of 
cases were attributed to recent transmission [2]. Of note, a similar 
proportion (approximately 70%) of MDR-TB cases due to trans-
mission was reported from Shanghai, China, where the prevalence 
of HIV infection is relatively low [1]. These studies of drug-resis-
tant tuberculosis suggest that transmission is the driving force of 
tuberculosis incidence in areas of high and low HIV prevalence.
The effects of different genotypes on transmission can be 
studied in high-incidence areas when M. tuberculosis genotypes 
are not concentrated in particular population subgroups. For 
example, there is some evidence from contact and molecu-
lar clustering and network studies that lineage 2 (East-Asian/
Beijing) and perhaps lineage 3 (East-African Indian) are more 
transmissible, whereas lineage 1 (Indo-Oceanic) and lineages 5 
and 6 (the Mycobacterium africanum strains) are the least likely 
to transmit and cause disease [57, 97]. This fits with the wide 
geographical reach of Beijing strains [98], compared with the 
more limited distribution of M. africanum.
A major limitation to the study of transmission in high-in-
cidence areas is the low sampling fraction (typically due to 
diagnostic delays or infrastructural limitations) and the repre-
sentativeness of cases in the study to all infectious tuberculosis 
in the population. In these settings, the proportion of undi-
agnosed but diagnosable tuberculosis cases that contribute to 
transmission is likely substantial [7]. Finally, measurement of 
transmission is more challenging in high-burden settings, as 
incident outbreaks may be obscured by the background multi-
plicity of circulating strains.
Areas of Low Tuberculosis Incidence
Key aspects of recent transmission, particularly measures of 
its relative size and scope, may be more readily discernible in 
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low-incidence areas, where discrete chains of transmission can 
be identified or estimated. Furthermore, where resources are 
dedicated to universal genotyping of all culture-confirmed cases 
and tuberculosis molecular surveillance is formally established, 
additional insight is possible through the combined use of clin-
ical, epidemiologic, and molecular data at the patient level [45, 
46]. For example, the estimate that approximately 14% of United 
States cases are attributed to recent transmission is a valu-
able indicator. These proportions are markedly higher among 
US-born persons (27%), compared with non–US-born persons 
(8%). However, considerable demographic and geographic het-
erogeneity in these estimates also exists, implying that specific 
subpopulations might be prioritized for targeted intervention.
A key goal is to detect and interrupt transmission early 
enough to prevent incident genotypes from becoming epidemi-
ologically entrenched in the population. In the United States, 
molecular surveillance [99] to detect and characterize clusters 
that may represent recent transmission has facilitated progress 
toward this goal [100]. In tandem, rapid uptake of technologies 
for WGS and phylogenetic analysis of select clusters that likely 
represent recent transmission has shown considerable promise 
in more precisely identifying outbreaks and outbreak-related 
cases. Thus, focused interventions to interrupt transmission 
and avoidance of unnecessary, resource-intensive investigations 
can often be effectively accomplished.
Even within low-incidence areas, however, high-incidence 
settings have been identified. Large clusters of prevalent gen-
otypes can become entrenched due to prolonged, uncontrolled 
transmission within relatively closed populations of persons with 
limited access to clinical and public health services. Examples 
include long-standing outbreaks among urban homeless popula-
tions in major US cities [47] and impoverished rural settings with 
minority and indigenous populations [101]. In such settings, the 
ability to distinguish cases due to the reactivation of remotely 
acquired infection from cases of recent transmission with rapid 
progression to disease is often confounded by minimal strain 
diversity, even at the level of SNPs [102]. Thus, health officials 
must epidemiologically investigate local drivers of transmission 
so that prevention measures to find and treat latent M. tuberculo-
sis infection and active case finding to characterize and interrupt 
transmission can be prioritized and accomplished effectively.
DISCUSSION
We have presented evidence that the drivers of tuberculosis trans-
mission in high-burden and low-burden settings appear markedly 
different. In high-burden settings, a large proportion of tuberculo-
sis cases are due to recent transmission, and the burden of disease 
among infants and children is considerable. In contrast, the major 
proportion of tuberculosis in low-burden settings results from 
remote transmission, and the age distribution of tuberculosis is 
skewed toward older ages. In settings with lower burdens of tuber-
culosis, chains of transmission are more easily identified, whereas 
in settings with high tuberculosis burden, it is often more difficult 
to distinguish individual chains of transmission from the large 
quantity of background transmission. Institutional amplifiers, such 
as homeless shelters and prisons, may exist in both low-burden and 
high-burden settings. Within the extremes of tuberculosis burden, 
however, there remains considerable heterogeneity in transmis-
sion. It is possible therefore to view transmission as part of a contin-
uum. In high-burden settings, endemic transmission results from 
a complex interplay between community and institutional amplifi-
ers, resulting in generalized endemic tuberculosis. With improve-
ment in general socioenvironmental factors, endemic tuberculosis 
continues to be transmitted in an increasingly smaller number of 
sites, resulting in more localized endemic tuberculosis restricted to 
subpopulations. As the proportion of the population affected by 
endemic transmission reduces further, it becomes easier to identify 
incident outbreaks, which often result from a highly infectious case 
in specific enabling environments. Thus, the expected transition in 
the nature of transmission would be a spectrum from long-stand-
ing (prevalent) outbreaks and endemic transmission occurring 
through institutional and community amplifiers, together with 
unrecognized, incident outbreaks occurring in higher-burden 
areas, to incident outbreaks increasingly being detected predom-
inantly in lower-burden areas. A summary of key factors influenc-
ing transmission is depicted in Figure 1.
Owing to the relative ease of measuring tuberculosis trans-
mission between contacts made within the confined household 
environment, household transmission and case notification rates 
in children have been used as end points to quantify the popu-
lation-level impact of transmission control measures. However, 
household transmission in high-burden settings has been shown 
to represent a relatively small proportion of all tuberculosis trans-
missions. This may be because the highly associative mixing of a 
small number of household members does not necessarily reflect 
the actual transmission drivers resulting from an array of commu-
nity and institutional tuberculosis amplifiers. Whereas household 
contact studies might reflect populations with relatively homoge-
neous tuberculosis transmission risk, the actual heterogeneity of 
tuberculosis transmission increases the complexity of the house-
hold-to-population transmission relationships. Transmission 
within institutions, such as homeless shelters and prisons, con-
tribute significantly to population burden. Identification and 
control in sites with the highest transmission risks appears to 
provide a disproportionate benefit for tuberculosis control.
The tuberculosis caseload observed within subpopulations 
and settings may conflate estimates of recent transmission, 
including both infection and progression to disease risks. 
However, newer technologies can help distinguish true out-
breaks from pseudo-outbreaks. For example, the use of proxim-
ity detection (eg, global positioning system mapping) or carbon 
dioxide monitoring has helped identify socioenvironmental hot 
spots of transmission, including public transportation, churches, 
schools, and bars [103]. Molecular methods, such as WGS, offer 
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greatly improved resolution, compared with earlier genotyping 
methods, which have overestimated true transmission chains. 
Nonetheless, molecular methods remain limited to patients 
with culture-positive sputum specimens and still require inter-
pretation within a framework of conventional epidemiology. 
Moreover, studies that rely on a passive case detection system 
are likely undersampling all of the infectious cases that remain 
undiagnosed but diagnosable [7, 104]. The contribution of such 
cases to tuberculosis incidence has yet to be determined.
In summary, it is important to recognize the heterogeneity of 
tuberculosis transmission in determining effective control strat-
egies for a population (Figure 1). While tuberculosis treatment 
has a survival benefit for the patient with tuberculosis, it can 
also decrease the prevalence of tuberculosis in a community. 
However, population-level tuberculosis control strategies to 
interrupt transmission need to be targeted at the overall trans-
mission pathways that predominate. When endemic tubercu-
losis is widespread, the focus should be on identifying specific 
community and institutional tuberculosis amplifiers and hot 
spots of transmission. In localized endemic tuberculosis, case 
finding and environmental control measures should target 
highly burdened subpopulations. In incident outbreaks, early 
molecular identification, control of source cases with treat-
ment for active disease, and identification of high risk contacts 
would be favored. Gaps in our knowledge of the factors driv-
ing transmission (Figure 2), including the contribution of the 
infective inoculum, the role of differentially culturable bacilli, 
the spectrum of infectiveness of tuberculosis sources, and how 
M. tuberculosis bacilli phenotypically adapt to survive outside 

















Figure 1. Factors influencing transmission.
- Where is the majority of transmission occurring (e.g. household, 
community, transport sites, schools, etc.)? 
- Determining the attributable fraction of key population level factors 
(e.g. specific institutional and community drivers) on TB 
transmission.
- The extent and role of missed (undiagnosed but diagnosable) 
individuals in maintaining TB incidence in the community
- Can genomic methods be optimized to define population level 
transmission? What are key additional data necessary for 
transmission studies (e.g. spatial, demographic, etc)?
- Are expelled M. tuberculosis particles physiologically di erent and similarly
infectious from those in sputum?
- Role of di erentially culturable bacilli in TB transmission.
- Are some clinical strains of M. tuberculosis more transmissible than other? How 
to measure epidemiologically? 
Figure 2. Some key questions relevant for transmission studies.
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